How To Repair Scar Tissue Ureter

Asian J Urol. 2022 Apr; 5(2): 69–77.

Overcoming scarring in the urethra: Challenges for tissue engineering science

Abdulmuttalip Simsek

^aDepartment of Urology, Royal Hallamshire Infirmary, Sheffield, UK

^bDepartment of Materials Science & Engineering, Kroto Inquiry Institute, University of Sheffield, Sheffield, UK

Reem Aldamanhori

^aDepartment of Urology, Royal Hallamshire Hospital, Sheffield, UK

Christopher R. Chapple

^aDepartment of Urology, Royal Hallamshire Hospital, Sheffield, United kingdom of great britain and northern ireland

Sheila MacNeil

^bDepartment of Materials Scientific discipline & Engineering, Kroto Enquiry Plant, Academy of Sheffield, Sheffield, UK

Received 2022 Nov 9; Revised 2022 Apr 21; Accepted 2022 Oct thirty.

Abstruse

Urethral stricture affliction is increasingly common occurring in nearly one% of males over the age of 55. The stricture tissue is rich in myofibroblasts and multi-nucleated giant cells which are idea to be related to stricture germination and collagen synthesis. An increase in collagen is associated with the loss of the normal vasculature of the normal urethra. The bodily incidence differs based on worldwide populations, geography, and income. The stricture aetiology, location, length and patient'southward historic period and comorbidity are important in deciding the class of treatment. In this review we aim to summarise the existing noesis of the aetiology of urethral strictures, review current handling regimens, and nowadays the challenges of using tissue-engineered buccal mucosa (TEBM) to repair scarring of the urethra. In asking this question we are likewise mindful that recurrent fibrosis occurs in other tissues—how can we learn from these other pathologies?

Keywords: Urethral strictures, Fibrosis, Tissue-engineered buccal mucosa, Augmentation urethroplasty

1. Introduction

Urethral strictures are an abnormal narrowing of the urethra. The origins of this fibrosis may be due to intrinsic weather merely commonly occur in response to impairment or infection [1]. They represent a scarring of the vascular corpus spongiosum leading to fibrosis [two]. There are varying degrees of spongiofibrosis but obstacle of the urethra can crusade infection, bladder calculi, fistulas, sepsis, and renal failure.

Overall the incidence of urethral strictures is nigh 1% in the males over the historic period of 55. The actual incidence differs based on worldwide populations, geography, and income [1], [3].

Direction of strictures varies from less invasive techniques such as urethral dilatation and urethrotomy, to more invasive procedures such equally anastomotic and commutation urethroplasty [iv]. In patients who accept extensive disease, obtaining sufficient graft can be challenging. For this reason, tissue-engineered buccal mucosa (TEBM) for the treatment of circuitous strictures was developed [5], [six].

2. Urethral stricture and histopathology

The normal urethra is lined by pseudo stratified columnar epithelium anchored to a basement membrane beneath which there is connective tissue composed of fibroblasts in an extracellular matrix composed of collagen, proteoglycans, elastic fibres and glycoproteins. Under this is the spongiosum composed of vascular sinusoids and smooth muscle. The pathological changes associated with strictures show that the normal epithelium becomes replaced with squamous metaplasia [7]. All strictures involve some injury to the epithelium of the urethra or corpus spongiosum and fibrosis occurs during the subsequent healing procedure.

This stricture tissue is rich in myofibroblasts and multi-nucleated behemothic cells which are thought to be related to stricture formation and collagen synthesis, respectively. An increase in collagen is associated with the loss of the normal vasculature of the normal urethra. Singh and Blandy [8] reported an experimental study in the rat to make up one's mind the office of extravasation of urine in the pathogenesis of urethral stricture. They observed that the ultrastructure of urethral stricture tissue suggested that some strictures were gristly while others were more resilient, and the total corporeality of collagen increased in urethral strictures, resulting in dense fibrotic tissue with decreased smooth musculus tissue and decreased elasticity. In contrast, Baskin et al. [9] could not demonstrate an increase in the total amount of collagen in strictures compared with the normal urethra, but rather plant that an alteration in the ratio of collagen type may explain the fibrotic, not-compliant nature of urethral stricture scar tissue. They found that the normal urethral spongiosum was composed of 75% blazon I collagen and 25% type III collagen. In contrast, the type III collagen in urethral stricture tissue was increased to 84% with a respective decrease in blazon I collagen (to 16%). These changes were accompanied by a decrease in the ratio of polish muscle to collagen, besides as changes in the synthesis of nitric oxide in the urethral stricture tissue [10]. Glycosaminoglycans (GAGs) and collagens are major components of the extracellular matrix and they have fundamental roles in fibrotic diseases. Da-Silva et al. [11] measured the GAG limerick in the strictured urethral segment. They concluded that limerick changes in GAGs could contribute to the not-compliant nature of urethral scar tissue and cause functional changes. Anterior urethral strictures normally occur after trauma or inflammation, and result in spongiofibrosis. Posterior urethral strictures mostly effect from iatrogenic injury or occur after pelvic fractures. These injures are contractures or stenosis of the urethra rather than true strictures.

ii.1. Aetiology of urethral strictures

Urethral stricture disease tin can occur due to several different aetiologies (Table ane) [12]. Strictures can be due to iatrogenic, idiopathic, inflammatory or traumatic causes. The largest category is actually iatrogenic resulting from urethral manipulations, related to placing of indwelling catheters, transurethral manipulation, surgery for hypospadias, prostatectomy, and brachytherapy [xiii], [14] (Fig. 1). Strictures can also occur due to trauma associated with pelvic fractures and in approximately sixty% of patients the function of the distal sphincter mechanism and hence continence depends on the integrity of the float neck. Moving on to infection, untreated gonorrhoea and chlamydia causing urethritis can lead to strictures. Another inflammatory disease associated with urethral stricture is balanitis xerotica obliterans. This is a chronic inflammatory disease whose aetiology is still unknown [fifteen].

An external file that holds a picture, illustration, etc. Object name is gr1.jpg

Iatrogenic stricture aetiology (%) past location [13].

Table ane

Stricture aetiology by location [12].

	Penile, %	Bulbar, %
Iatrogenic	forty	35
Idiopathic	xv	40
Inflammatory	twoscore	10
Traumatic	5	15

3. Clinical evaluation

The first of import step in the evaluation of a patient and the decision about treatment is to obtain a thorough history to go as much information equally possible about the aetiology behind the urethral stricture. This requires documenting the onset and severity of obstructive and storage-related voiding symptoms. In add-on to this history, uroflowmetry is widely used in the cess of the urethral stricture. Retrograde urethrography is used to provide information on stricture location and length. Moreover, retrograde and antegrade cystourethrographies are recommended to assess posterior urethral strictures and float neck function [sixteen]. Cystoscopy can bear witness the location and caste of the stricture, but if the stricture cannot be passed, no information tin can be obtained. Some other diagnostic procedure is ultrasonography which can be helpful in the assessment of the stricture length and the degree of spongiofibrosis [17].

four. Direction

Treatment of urethral strictures depends on stricture aetiology, localisation (anterior or posterior), the length of stricture, the degree of spongiofibrosis, the previous history of treatment, and the patient's age. Theoretically, curt simple strictures are treated endoscopically, however long circuitous strictures oft require one- or two-phase urethroplasty (Fig. two).

An external file that holds a picture, illustration, etc. Object name is gr2.jpg

Algorithm of anterior urethral stricture treatment (A) and bulbar urethral stricture handling (B) [iv].

iv.ane. Urethral dilation and internal urethrotomy

There are several methods for urethral dilatation. These encompass sequential dilatation with metal sounds though filiform dilations, followers, dilation with a balloon, and self-dilation with catheters. The success of these all depends on the regeneration of epithelium without it leading to further restenosis. For patients with an epithelial stricture without spongiofibrosis, dilatation can be curative and overall in that location is no deviation in recurrence rates following internal urethrotomy versus urethral dilation [18], [19].

Internal urethrotomy [19] is performed by a cold-pocketknife transurethral incision to release stricture tissue. The goal is to provide a minimally invasive handling that achieves a patent urethra to permit unobstructed voiding with minimal side effects. For the urethra to remain patent, reepithelialization must occur at a faster rate than wound contracture [xx]. For patients who are advisedly selected with optimal stricture characteristics, primary bulbar strictures of <1 cm which are soft, so a stricture-gratis rate of upward to l%–lxx% can exist achieved. Thus, urethrotomy remains the kickoff-line therapy for these selected patients [21], [22]. Steenkamp et al. [xix] reported long-term success rates of simply 20%. Patients with longer (>2 cm in length), multiple, penile or distal strictures and extensive periurethral spongiofibrosis typically practice not reply well to repeat incisions. Thus repeat internal urethrotomy offers no real gamble of a cure after a third incision or if the stricture recurs within 3 months of the first incision. Such patients should be offered urethroplasty [23], [24].

Some studies have evaluated the efficacy of agents injected into the scar tissue at the site of stricture area every bit an internal urethrotomy process to decrease recurrence rates. For case mitomycin C was used for anterior urethral stricture and float neck contractions. Authors establish that after xv months mean follow-up urethral stricture recurred in 10% urethral stricture patients in the mitomycin C treated group and in 50% of patients in the untreated group [25], [26]. Some other written report evaluated the employ of triamcinolone injection and showed a meaning decrease in recurrence charge per unit [27], [28]. Incision/dilation followed by long-term self- or office dilation is an alternative pick for men with severe comorbidities or limited life expectancy, or for those who have failed prior reconstruction with no further available surgical options.

Internal urethrotomy can have complications such every bit urethral hemorrhage, perineal hemorrhage and extravasation of irrigation into perispongiosal tissues, scrotal oedema, creation of a false passage, rectal perforation, epididymo-orchitis, meatal stenosis, incontinence, fever, bacteremia, urinary sepsis, and scrotal abscess. With deep incisions at the ten o'clock and two o'clock positions, in that location is besides a risk of entering the corpus cavernous and creating fistulas between corpus spongiosum and cavernous, leading to erectile dysfunction [28], [29], [xxx], [31]. Overall, notwithstanding, the incidence of these complications is around ii%–x% simply in addition there can be recurrence of the urethral strictures.

While the process can be done with common cold-knife at that place have been studies [32], [33], [34] looking at the use of lasers for the treatment of urethral strictures. Many different types of lasers have been used including argon, carbon dioxide, excimer, diode, KTP and Nd:YAG lasers. Unfortunately the bottom line is that the addition of lasers has non improved success rates compared to cold-knife urethrotomy.

5. Urethroplasty

5.ane. Excision and primary anastomosis

The lowest re-stricture rate with least complications is achieved by excising the stricture, particularly where this is a short bulbar urethral stricture of <2 cm in length and achieving an anastomosis of the two good for you ends on either side [2], [35]. Success rates are reported to exist between 90% and 95% [36], [37], [38], [39].

The length that can be gained depends on the anatomy of the individual patient, as well as the length and elasticity of the distal urethral segment, and more than peculiarly, the size of the penis and urethra. By separating the corpora or freeing the urethra from the corpus cavernous up to the peno-scrotal junction as much as 2–4 cm in length tin be gained. Additionally, younger men may have amend tissue compliance, increasing the chances of successful primary re-anastomosis for long strictures [38].

This excision and primary anastomosis appears to have a negligible effect on penile shortening or chordae if more than than 2 cm of urethra is excised. Another important complication is sexual dysfunction. Erickson et al. [40] found that when patients did report postoperative erectile dysfunction after urethral reconstruction, it tended to be transient, with the vast bulk of patients recovering preoperative erectile part within 6 months of surgery. Erectile part may be influenced by patient age, stricture length and location, and the method of reconstruction.

5.2. Augmentation urethroplasty

Augmentation urethroplasty is traditionally used for strictures longer than 2 cm for which an anastomotic urethroplasty is not suitable for surgery. These techniques are recommended to accomplish a tension free anastomosis and to avoid chordae. Augmentation urethral reconstruction tin exist a one-stage or a two-phase procedure.

At that place are three potential options with a one-stage procedure:

i)

An augmented anastomotic procedure; Stricture excision and and then restore a roof or floor strip of native urethra augmented with a patch.
2)

An onlay augmentation process. This is incision of stricture with an onlay patch to the urethral roof or floor strip.
3)

A tube augmentation: Excise the stricture and put in a circumferential patch. This procedure is associated with loftier recurrence rates [41], [42].

A two-stage procedure involves excision of the stricture and the abnormal urethra and reconstruction of a roof strip, which is allowed to heal prior to 2d-stage tubularisation.

Another approach to urethroplasty is the utilise of a graft or flap. This was viewed as controversial merely it is now clear from a review of the literature that the stricture recurrence rate is 14.5%–15.7% using either a flap or graft [43]. Thus there is no reward in the use of a flap over a straightforward graft in terms of stricture recurrence. In carrying out an augmentation procedure, one must as well consider whether full-thickness tissue or fractional-thickness tissue should exist used; Partial-thickness tissue has a greater propensity to contract than does full-thickness tissue. This is exactly the aforementioned every bit what is found with graft contraction in divide-thickness skin where thinner skin grafts contract to a much greater extent than exercise thicker peel grafts [44].

A range of materials accept been used for grafting including penile skin, scrotal skin, oral mucosa, bladder mucosa, and colonic mucosa. From these oral mucosa grafts have go the nigh clinically accepted due to their graft brusque harvest fourth dimension, a lack of pilus, low morbidity, and their high clinical success rates [45], [46], [47], [48]. Oral mucosa is taken as total-thickness and most patients can provide an adequate donor area. Oral mucosa tin be harvested from the cheek (buccal mucosa), from the lip (labial mucosa), or from the undersurface of the natural language (lingual mucosa). Labial mucosa can be managed in a similar fashion, only is much thinner and more than difficult to handle, and has go associated with greater morbidity. Reported complications of oral mucosal grafts include intraoperative hemorrhage, postoperative infection, pain, swelling, and damage to salivary ducts. In some cases, patients note initial limitation of oral opening, although this is usually transient. Occasionally there can be loss or alteration of sensation within the cheek. Barbagli et al. [49] reported that 98.4% would undergo the surgery again and concluded that harvesting from a single cheek with closure of the donor site was a safe procedure with high patient satisfaction.

There are several dissimilar approaches to the augmentation procedure. For onlay augmentation, the option is a ventral, lateral, or dorsal approach. Dorsal and ventral onlay grafts have comparable success rates of 88% at three years [50]. There is likely to be less bleeding from an incision in this airplane and potentially less interference with blood supply as 1 extends into the proximal and distal normal urethra. Barbagli et al. [51] described lateral onlay augmentation and success charge per unit remained at 83% over the follow-upwardly menses.

Two-phase reconstruction should be considered later hypospadias repair or in the presence of lichen sclerosus (LS) or when at that place are other concerns well-nigh the success of whatever reconstructive procedure in the penile urethra. Several months elapse while the first-stage reconstruction heals and only when it is adequate for closure is the urethra retubularised. After offset-phase urethral reconstruction 10%–39% of patients show contraction because of scarring initial graft unfortunately [52]. For example, nearly 15% of men treated for urethral strictures have a history of failed hypospadias repair [53]. Treatment of adults with recurrent strictures is hard because of the poor blood supply, urethral shortening from prior surgery, the degree of inflammation and the scarring itself.

In complex strictures due to previously failed hypospadias or LS, these may require second-stage urethroplasty with buccal mucosa. Commonly these patients require big areas of buccal mucosa grafting.

5.3. Graft contraction or failure

While contraction of grafted tissue mail urethral surgery is a relatively mutual postoperative complication which usually requires further surgery, this is non a unique state of affairs. Pare grafts, for instance, usually contract.

The mechanism of peel or oral mucosa contraction is a normal physiological phenomena which reduces the area of the graft. The graft wrinkle occurs in two-stages. When the graft is first harvested from the donor side, it undergoes an initial reduction in size called master contraction. This can range from nine% to 22% dependent on the thickness of the graft [54]. The thicker the skin grafts are, the more elastin fibres will exist nowadays in the dermis and the greater these contract. Thus full-thickness grafts exhibit the greatest degree of primary contraction and split-thickness grafts with less elastin fibres contract less and pure epidermal grafts fail to contract [54]. When grafts are placed on their recipient wound beds then they undergo secondary contraction. This is the wrinkle that is of clinical concern. This wrinkle reduces both the size of the graft and the circumference of the graft at its periphery, with the edges of the graft contracted towards the middle [55]. For secondary graft contraction, separate-thickness grafts contract more total-thickness grafts [56]. It is thought that this is due to the difference in matrix limerick between the dermal layers within the grafts [57]. Epidermal hyperplasia and dermal fibrosis are less prominent in full-thickness grafts than carve up-thickness grafts at 4 weeks after grafting [57].

Certainly it is known that the graft bed and the recipient exert a major influence on the caste of contraction. Grafting onto more mobile tissues results in more wrinkle. As well age plays a big role. Grafts in paediatric patients contract more often and to a greater extent than in adults. This may be related to the growth gene profile of children compared to adults [47], [58], [59]. Looking at the cellular mechanisms of contraction at that place is considerable evidence that contraction occurs secondary to the differentiation of fibroblasts to form myofibroblasts with expression of alpha-actin filament bundles. These myofibroblasts possess intrinsic contractile properties similar to smoothen muscle cells. As the myofibroblasts are adherent both to one another and to the fibronectin-rich wound bed, the entire mass of granulation tissue contract [threescore], [61], [62]. Keratinocytes are also capable of contracting collagen gels in vitro and their part is increasingly recognised in vivo [63]. Keratinocytes possess strong intercellular adhesions, with cultured confluent sheets of keratinocytes quickly contracting to 70% of their original area post-obit disengagement from tissue culture plastic in vitro [64]. Keratinocytes are too effective at contracting collagen gels when they are seeded on the top of the gel. This mimics the in vivo situation, in which the keratinocytes migrate across the wound surface during reepithelialisation. At relatively depression densities of surface-seeded keratinocytes, the contraction is equivalent to that seen with much college densities of gel-incorporated human dermal fibroblasts [65].

Our group has developed a 3D tissue engineered model of human skin, based on sterilised homo dermis. This is seeded with laboratory-expanded human being keratinocytes and fibroblasts and cultured at an air–liquid interface [66], [67]. This tissue-engineered skin is based on normal mature human cross-linked collagen. Information technology retains a basement membrane [68], to which keratinocytes adhere firmly and class a stratified epithelium, while fibroblasts penetrate and migrate through the dermis. This tissue engineered skin contracts by 25%–xl% during 10 days of culture in vitro [69], [70] and by up to 60% over thirty days of culture [67]. It appears that keratinocytes contract the dermis as they differentiate. Increasing keratinocyte differentiation with Vitamin C provokes premature differentiation and hyperkeratosis with a marked increase in keratinocyte-driven contraction of the tissue-engineered pare [70]. This change appears to be mediated by covalent crosslinking of next collagen fibrils. Civilization of tissue-engineered skin with β-aminopropionitrile (β-APN), an inhibitor of the lysyl oxidase crosslinking enzyme, leads to a reduction in contraction in vitro [67]. These findings have also been seen in a fibroblast-impregnated collagen gel model where lysyl oxidase-catalysed collagen crosslinking is observed during the contraction procedure and once more this contraction can exist inhibited by β-APN [71]. Interestingly this keratinocyte-mediated wrinkle can be reduced in vitro by suturing the tissue engineered skins to a rigid frame for a number of days [72]. Information technology is known that peel graft contracture is more than severe in children than in adults, although the reason for this is not clear. There are changes in transforming growth cistron-β (TGF-β) expression with age and a reduction in expression of TGF-β1 and TGF-β2 expression with ageing, accompanied by an increase in TGF-β3 [41]. Up-regulations of TGF-β1 and TGF-β2 have been proposed every bit a primary mechanism for hypertrophic and keloid scarring [73]. Insulin-similar growth factor-1 (IGF-1) plays a major role in wound healing [74]. Synthesis of IGF-ane leads to increased collagen synthesis and deposition [75]. It shares many fibrogenic characteristics with TGF-β1 and is establish in elevated levels in hypertrophic scar tissue when compared with patient matched normal pare [76]. Using a tissue engineered model of skin in vitro, IGF-1 was found to have no significant effect on contraction [67]. Similarly add-on of exogenous basic fibroblast growth factor (bFGF), neoplasm necrosis factor-α (TNFα) and prostaglandin-E2 (PGE2) had no effect on wrinkle [67]. Interestingly, culture with estradiol resulted in a marked increase in wrinkle, although the reason for this is unclear.

In 2008 there was a randomized comparative study of 30 patients who were treated either with native buccal mucosa or an acellular bladder matrix graft. It was found that the results were related to the number of previous interventions. In patients who had less than ii prior operations, the success rate of the bladder matrix graft was 8 out of nine cases but for those who had more than two operations, iv out of the half dozen patients were unsuccessful. This written report showed that the best results were obtained in patients with a good for you urethral bed, no spongiofibrosis and adept urethral mucosa [77].

In 2008 we reported the first use of tissue-engineered buccal mucosa for extensive substitution urethroplasty in 5 patients and here we reported on a 3-twelvemonth follow-up. We found that initial results were good in all five patients with rapid vascularisation of the grafts and retubularisation of all five patients occurred as though native buccal mucosa had been used. However, after 8 and nine months respectively, ii of the five patients' grafts developed contraction and fibrosis. One graft was completely removed and one was partially removed and replaced past native buccal mucosa. Histology of the ii excised grafts showed pronounced epithelial hyperproliferation and fibrosis [5].

A recent 9-year follow-up in 2022 showed no further fibrosis for the 4 patients who had tissue engineered buccal mucosa withal in place. In this study all the patients had same aetiology with pregnant LS [6].

In 2022 there was a report of the utilise of tissue engineered autologous urethrografts for patients who needed reconstruction. Another cell-seeded scaffolds were used in a series of five pediatric patients with posterior urethral stricture, a tissue biopsy was taken from each patient, and the muscle and epithelial cells were seeded onto tubularised polyglycolic acid:poly (lactide-co-glycolide acid) scaffolds. Patients and so underwent urethroplasy with tissue engineered scaffolds. Median follow-up was 71 months and successful in 4/5 patients, and 1/5 patients required transurethral incision 4 weeks after surgery. The patient was able to void well without further interventions [72]. In 2022 a report was published of half dozen pediatric patients with severe hypospadias who were treated with urothelial cells seeded onto an acellular dermis graft. Follow-up was for a median of 7.25 years. Five out of the six patients had a adept cosmetic appearance and result. In ane patient an internal urethrotomy was performed 1 year after urethroplasy [78].

Subsequently these mixed clinical results we decided we needed to undertake further investigation of the mechanism of wrinkle of TEBM in vitro before going forward clinically.

Our showtime report of contraction of TEBM showed that they lost a mean of 45.4% of their original expanse over 28 days of civilisation. Treating TEBM with glutaraldehyde, β-APN, or mechanical restraint during civilization all significantly inhibited graft contraction. Glutaraldehyde treatment was most effective during culture reduction graft contraction [79].

Several studies reported long-term success rates of urethroplasty with patient's buccal mucosa graft [41], [42], [43], [45], [46], [47], [48], [49], [50], [51]. A few studies published multivariate assay of urethroplasy out-comes examining preoperative parameters predictors of recurrence (Table 2). Breyer et al. [lxxx] reported their cohort of 445 patients undergoing urethroplasy with mean 5.8 years follow-up period. They determined an overall recurrence rate of 21%. A history of smoking and prior urethral surgery (internal urethrotomy or urethroplasty) were constitute to be significant predictors for recurrence. The authors also noted that about of the recurrence occurred within the first 2 years. Another report found the average time to recurrence was 11.seven months, with recurrence occurring betwixt two weeks and 77 months and these authors also noted that recurrences by and large occurred early within the beginning 6 months [81]. Multivariate analysis showed that long stricture length (>5 cm), LS, iatrogenic and infection were all associated with recurrence [81]. Warner et al. [82] maintained that second-stage urethroplasties had a higher recurrence rate compared with kickoff-stage urethroplasty for LS cases. More than recently, Han et al. [83] examined their cohort of urethroplasty patients and showed results of their multivariate assay and institute prior urethroplasty was a predictor of follow-upwards but critically more strictures were detected on longer term follow-up after urethroplasty. Authors establish a hateful time to recurrence of 34 months, with recurrences occurring equally late at 87 months. On multivariate analysis, if follow-up exceeded 48 months there was a statistically significant increase in recurrence existence detected. These results confirm that belatedly recurrences practice occur even across 5 years of follow-upwardly.

Tabular array 2

Run a risk factors for stricture recurrence [80], [81], [82], [83].

Factors	Risk ratio (range)
Diseases
Smoking	i.8 (ane.0–iii.1)
Diabetes mellitus	2.0 (0.8–4.9)
Chronic obstructive pulmonary affliction	ane.3 (0.4–4.4)
Connective tissue affliction	1.3 (0.3–4.7)
Coronary avenue disease	1.0 (0.4–ii.five)
Stricture aetiology
Trauma	2.6 (0.98–half dozen.9)
Iatrogenic	three.four (1.2–10)
Infectious	7.three (2.three–23.vii)
Lichen sclerosus	five.9 (ii.1–16.five)
Radiation	3.3 (0.8–14)
Location
Inductive	0.49 (0.2–ane.2)
Posterior	0.67 (0.3–1.7)
Panurethral	ane.4 (0.38–5)
Prior treatment
Urethroplast	half dozen.9 (ii.ane–22.6)
Urethrotomy	0.8 (0.two–2.8)
Dilation	0.7 (0.3–1.4)
Hypospadias	1.half-dozen (0.vii–3.9)
Stricture length >5 cm	2.3 (1.two–4.5)
Age	0.99 (0.98–1.01)

Fibrosis is an important pathology which tin can occur in many other tissues—liver cirrhosis, atherosclerosis, Dupuytren's contracture, and glomerulosclerosis. For these diseases, early pathogenesis of fibrosis is related to inflammation and the final pathways of fibrogenesis are similar and stereotypical. Alcoholic liver cirrhosis is a fibrotic disease developing afterwards toxic impairment. In this pathology, circulating autoantibodies against acetaldehyde adducts and lipid peroxidation-derived antigens are detected [84]. T cells infiltrating the liver paranchyma are likewise the first sign of increased extracellular matrix (ECM), specially blazon Iii collagen. As long as type Iii collagen exists, fibrosis is still reversible, merely the appearance of type I collagen heralds an irreversible stage [85], [86]. Atherosclerosis is characterized by sclerosis of the arterial wall due to pathogenic fibrotic changes [87]. Similar other fibrotic disorders, an imbalance between profibrotic and antifibrotic cytokines induces fibroblast proliferation and hyper production of ECM [88]. Dupuytren's contracture is characterized past fibrotic nodules with progressive, wrinkle of the palmar fascia. The aetiology of this condition is still unclear. Pathological responses to traumatic stress factors may affect the microvasculature, leading to localized ischemia and the generation of oxygen-free radicals providing an inflammatory reaction in this disease. This inflammatory response is followed by the production of profibrotic TGF-β1. For this condition, fibroblast transdifferentiation into myofibroblasts are essential cellular components [89]. Another fibrotic pathology is glomerulosclerosis. Hither neutrophils are the first cells recruited to glomerula. Neutrophil degranulation, releasing inflammatory and profibrotic cytokines and macrophages are the primary source of TGF-β1, finally resulting in the finish-stage of glomerular fibrosis [90]. Unfortunately despite this noesis of the molecular and cellular mechanisms of fibrosis in other conditions fibrosis remains very difficult to treat. This research has non notwithstanding translated into clinically applicable diagnostic, preventive, and therapeutic measures.

In summary, urethral strictures are common and management of long segment strictures presents a challenging surgical trouble primarily because of stricture recurrence. At that place are clear predictors of which patients will be nigh affected—those with comorbidities of diabetes mellitus or coronary artery disease, smoking, stricture aetiology (iatrogenic, infectious or LS), long strictures stricture length, and prior urethroplasty. The use of TEBM offers an additional handling material merely it is non exempt from stricture recurrence. However what it does provide is an in vitro model in which to explore approaches to prevent or reduce tissue contraction. Our recent work looking at inhibitors of collagen crosslinking may offer an approach to reducing its severity in one case detected just this is an expanse where much more enquiry is needed to couple the clinical data on which patients are most at risk to early detection and somewhen treatment. Currently we conclude that it is an expanse of unmet clinical need where users of tissue engineered materials will demand to be cautious and reported on long-term clinical results.

Conflicts of interest

The authors declare no conflict of involvement.

Footnotes

Peer review under responsibility of Second Military Medical Academy.

References

1. Santucci R.A., Joyce Grand.F., Wise M. Male person urethral stricture illness. J Urol. 2007;177:1667–1674. [PubMed] [Google Scholar]

2. Warwick R.T. Urethral surgery. In: Mundy A.R., editor. Electric current operative surgery: urology. Balliere Tindall; London: 1988. pp. 160–218. [Google Scholar]

iii. Anger J.T., Buckley J.C., Santucci R.A., Elliott Due south.P., Saigal C.Southward. Trends in stricture direction amidst male person Medicare beneficiaries: underuse of urethroplasty? Urology. 2011;77:481–485. [PMC costless article] [PubMed] [Google Scholar]

5. Bhargava Due south., Patterson J.Thousand., Inman R.D., MacNeil S., Chapple C.R. Tissue-engineered buccal mucosa urethroplasty-clinical outcomes. Eur Urol. 2008;53:1263–1269. [PubMed] [Google Scholar]

6. Osman North.I., Patterson J.Thou., MacNeil S., Chapple C.R. Long-term follow-up after tissue-engineered buccal mucosa urethroplasty. Eur Urol. 2014;66:790–791. [PubMed] [Google Scholar]

7. Cavalcanti A.K., Costa W.S., Baskin L.S., McAninch J.A., Sampaio F.J. A morphometric analysis of bulbar urethral strictures. BJU Int. 2007;100:397–402. [PubMed] [Google Scholar]

8. Singh M., Blandy J.P. The pathology of urethral stricture. J Urol. 1976;115:673–676. [PubMed] [Google Scholar]

9. Baskin L.S., Constantinescu S.C., Howard P.South., McAninch J.W., Ewalt D.H., Duckett J.W. Biochemical characterization and quantitation of the collagenous components of urethral stricture tissue. J Urol. 1993;150:642–647. [PubMed] [Google Scholar]

x. Cavalcanti A.G., Yucel S., Deng D.Y., McAninch J.W., Baskin Fifty.S. The distribution of neuronal and inducible nitric oxide synthase in urethral stricture formation. J Urol. 2004;171:1943–1947. [PubMed] [Google Scholar]

eleven. Da-Silva East.A., Sampaio F.J., Dornas One thousand.C., Damiao R., Cardoso L.Due east. Extracellular matrix changes in urethral stricture illness. J Urol. 2002;168:805–807. [PubMed] [Google Scholar]

12. Mundy A.R., Andrich D.E. Urethral strictures. BJU Int. 2011;107:vi–26. [PubMed] [Google Scholar]

13. Lumen Due north., Hoebeke P., Willemsen P., De Troyer B., Pieters R., Oosterlinck W. Etiology of urethral stricture disease in the 21st century. J Urol. 2009;182:983–987. [PubMed] [Google Scholar]

14. Fenton A.Due south., Morey A.F., Aviles R., Garcia C.R. Inductive urethral strictures: etiology and characteristics. Urology. 2005;65:1055–1058. [PubMed] [Google Scholar]

fifteen. Das S., Tunuguntla H.South. Balanitis xerotica obliterans—a review. World J Urol. 2000;eighteen:382–387. [PubMed] [Google Scholar]

16. Miller Grand., Posh M., Brandes S.B. Urethral stricture and urethroplasy in the pelvic irradiated patient. In: Brandes Southward.B., editor. Urethral reconstructive surgery. Springer; Saint Louis: 2008. pp. 241–249. [Google Scholar]

17. McAninch J.Westward., Laing F.C., Jeffrey R.B., Jr. Sonourethrography in the evaluation of urethral strictures: a preliminary report. J Urol. 1988;139:294–297. [PubMed] [Google Scholar]

18. Steenkamp J.W., Heyns C.F., de Kock M.L. Outpatient treatment for male urethral strictures—dilatation versus internal urethrotomy. S Afr J Surg. 1997;35:125–130. [PubMed] [Google Scholar]

19. Steenkamp J.W., Heyns C.F., de Kock M.L. Internal urethrotomy versus dilation as handling for male urethral strictures: a prospective, randomized comparing. J Urol. 1997;157:98–101. [PubMed] [Google Scholar]

20. Tonkin J.B., Jordan 1000.H. Management of distal anterior urethral strictures. Nat Rev Urol. 2009;6:533–538. [PubMed] [Google Scholar]

21. Albers P., Fichtner J., Bruhl P., Muller S.C. Long-term results of internal urethrotomy. J Urol. 1996;156:1611–1614. [PubMed] [Google Scholar]

22. Pansadoro V., Emiliozzi P. Internal urethrotomy in the management of anterior urethral strictures: long-term followup. J Urol. 1996;156:73–75. [PubMed] [Google Scholar]

23. Heyns C.F., Steenkamp J.W., De Kock Thou.L., Whitaker P. Handling of male urethral strictures: is repeated dilation or internal urethrotomy useful? J Urol. 1998;160:356–358. [PubMed] [Google Scholar]

24. Naude A.M., Heyns C.F. What is the place of internal urethrotomy in the treatment of urethral stricture disease? Nat Clin Pract Urol. 2005;2:538–545. [PubMed] [Google Scholar]

25. Vanni A.J., Zinman L.N., Buckley J.C. Radial urethrotomy and intralesional mitomycin C for the direction of recurrent bladder cervix contractures. J Urol. 2011;186:156–160. [PubMed] [Google Scholar]

26. Mazdak H., Meshki I., Ghassami F. Effect of mitomycin C on inductive urethral stricture recurrence subsequently internal urethrotomy. Eur Urol. 2007;51:1089–1092. [discussion 92] [PubMed] [Google Scholar]

27. Tavakkoli Tabassi Grand., Yarmohamadi A., Mohammadi Southward. Triamcinolone injection following internal urethrotomy for treatment of urethral stricture. Urol J. 2011;8:132–136. [PubMed] [Google Scholar]

28. Mazdak H., Izadpanahi M.H., Ghalamkari A., Kabiri 1000., Khorrami M.H., Nouri-Mahdavi One thousand. Internal urethrotomy and intraurethral submucosal injection of triamcinolone in short bulbar urethral strictures. Int Urol Nephrol. 2010;42:565–568. [PubMed] [Google Scholar]

29. Jin T., Li H., Jiang Fifty.H., Wang L., Wang K.J. Safety and efficacy of laser and cold pocketknife urethrotomy for urethral stricture. Chin Med J. 2010;123:1589–1595. [PubMed] [Google Scholar]

30. McDermott D.W., Bates R.J., Heney N.M., Althausen A. Erectile impotence as complication of direct vision common cold knife urethrotomy. Urology. 1981;eighteen:467–469. [PubMed] [Google Scholar]

31. Graversen P.H., Rosenkilde P., Colstrup H. Erectile dysfunction post-obit direct vision internal urethrotomy. Scand J Urol Nephrol. 1991;25:175–178. [PubMed] [Google Scholar]

32. Dutkiewicz S.A., Wroblewski M. Comparing of treatment results between holmium laser endourethrotomy and optical internal urethrotomy for urethral stricture. Int Urol Nephrol. 2012;44:717–724. [PMC free article] [PubMed] [Google Scholar]

33. Atak Chiliad., Tokgoz H., Akduman B., Erol B., Donmez I., Hanci V. Low-power holmium:YAG laser urethrotomy for urethral stricture disease: comparison of outcomes with the cold-knife technique. Kaohsiung J Med Sci. 2011;27:503–507. [PubMed] [Google Scholar]

34. Hussain M., Lal M., Askari S.H., Hashmi A., Rizvi S.A. Holmium laser urethrotomy for treatment of traumatic stricture urethra: a review of 78 patients. JPMA. J Pak Med Assoc. 2010;threescore:829–832. [PubMed] [Google Scholar]

35. Webster Thousand.D., Ramon J. Repair of pelvic fracture posterior urethral defects using an elaborated perineal arroyo: feel with 74 cases. J Urol. 1991;145:744–748. [PubMed] [Google Scholar]

36. Eltahawy Due east.A., Virasoro R., Schlossberg S.Chiliad., McCammon K.A., Jordan G.H. Long-term followup for excision and primary anastomosis for anterior urethral strictures. J Urol. 2007;177:1803–1806. [PubMed] [Google Scholar]

37. Park Due south., McAninch J.W. Straddle injuries to the bulbar urethra: direction and outcomes in 78 patients. J Urol. 2004;171:722–725. [PubMed] [Google Scholar]

38. Cooperberg M.R., McAninch J.W., Alsikafi N.F., Elliott S.P. Urethral reconstruction for traumatic posterior urethral disruption: outcomes of a 25-twelvemonth experience. J Urol. 2007;178:2006–2010. [give-and-take 10] [PubMed] [Google Scholar]

39. Morey A.F., Kizer Westward.S. Proximal bulbar urethroplasty via extended anastomotic approach—what are the limits? J Urol. 2006;175:2145–2149. [give-and-take nine] [PubMed] [Google Scholar]

40. Erickson B.A., Granieri Yard.A., Meeks J.J., Cashy J.P., Gonzalez C.G. Prospective analysis of erectile dysfunction after anterior urethroplasty: incidence and recovery of part. J Urol. 2010;183:657–661. [PubMed] [Google Scholar]

41. Patterson J.Thousand., Chapple C.R. Surgical techniques in exchange urethroplasty using buccal mucosa for the treatment of inductive urethral strictures. Eur Urol. 2008;53:1162–1171. [PubMed] [Google Scholar]

42. Greenwell T.J., Venn S.N., Mundy A.R. Irresolute practice in anterior urethroplasty. BJU Int. 1999;83:631–635. [PubMed] [Google Scholar]

43. Wessells H., McAninch J.W. Current controversies in anterior urethral stricture repair: free-graft versus pedicled skin-flap reconstruction. World J Urol. 1998;16:175–180. [PubMed] [Google Scholar]

44. Harrison C.A., MacNeil S. The machinery of skin graft contraction: an update on current research and potential future therapies. Burns. 2008;34:153–163. [PubMed] [Google Scholar]

45. Lumen N., Oosterlinck W., Hoebeke P. Urethral reconstruction using buccal mucosa or penile skin grafts: systematic review and meta-analysis. Urol Int. 2012;89:387–394. [PubMed] [Google Scholar]

46. Barbagli 1000., Sansalone Southward., Djinovic R., Romano M., Lazzeri Grand. Current controversies in reconstructive surgery of the anterior urethra: a clinical overview. Int Braz J Urol. 2012;38:307–316. [discussion 16] [PubMed] [Google Scholar]

47. Barbagli One thousand. When and how to use buccal mucosa grafts in penile and bulbar urethroplasty. Minerva Urol Nefrol. 2004;56:189–203. [PubMed] [Google Scholar]

48. Markiewicz M.R., Lukose M.A., Margarone J.E., third, Barbagli Grand., Miller K.S., Chuang S.K. The oral mucosa graft: a systematic review. J Urol. 2007;178:387–394. [PubMed] [Google Scholar]

49. Barbagli G., Vallasciani Due south., Romano G., Fabbri F., Guazzoni G., Lazzeri M. Morbidity of oral mucosa graft harvesting from a single cheek. Eur Urol. 2010;58:33–41. [PubMed] [Google Scholar]

50. Mangera A., Patterson J.M., Chapple C.R. A systematic review of graft augmentation urethroplasty techniques for the treatment of anterior urethral strictures. Eur Urol. 2011;59:797–814. [PubMed] [Google Scholar]

51. Barbagli Thousand., Palminteri E., Guazzoni G., Montorsi F., Turini D., Lazzeri Grand. Bulbar urethroplasty using buccal mucosa grafts placed on the ventral, dorsal or lateral surface of the urethra: are results affected past the surgical technique? J Urol. 2005;174:955–957. [discussion seven–8] [PubMed] [Google Scholar]

52. Barbagli G., De Angelis M., Palminteri E., Lazzeri 1000. Failed hypospadias repair presenting in adults. Eur Urol. 2006;49:887–894. [discussion 95] [PubMed] [Google Scholar]

53. Barbagli K., Perovic S., Djinovic R., Sansalone Southward., Lazzeri M. Retrospective descriptive analysis of ane,176 patients with failed hypospadias repair. J Urol. 2010;183:207–211. [PubMed] [Google Scholar]

54. Davis J.S., Kitlowski Due east.A. The Immediate contraction of cutaneous grafts and its crusade. Arch Surg. 1931;23:954–965. [Google Scholar]

55. Hinshaw J.R., Miller Eastward.R. Histology of healing split-thickness, full-thickness autogenous pare grafts and donor sites. Arch Surg. 1965;91:658–670. [PubMed] [Google Scholar]

56. Corps B.5. The effect of graft thickness, donor site and graft bed on graft shrinkage in the hooded rat. Br J Plast Surg. 1969;22:125–133. [PubMed] [Google Scholar]

57. Rudolph R. The effect of skin graft preparation on wound contraction. Surg Gynecol Obstet. 1976;142:49–56. [PubMed] [Google Scholar]

58. Davies D.M. Plastic and reconstructive surgery. Scars, hypertrophic scars, and keloids. Br Med J (Clin Res Ed) 1985;290:1056–1058. [PMC free article] [PubMed] [Google Scholar]

59. Rudolph R. Contraction and the control of wrinkle. World J Surg. 1980;four:279–287. [PubMed] [Google Scholar]

sixty. Gabbiani Thousand., Majno G. Dupuytren's contracture: fibroblast wrinkle? An ultrastructural written report. Am J Pathol. 1972;66:131–146. [PMC free commodity] [PubMed] [Google Scholar]

61. Tomasek J.J., Haaksma C.J. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue. Anat Rec. 1991;230:175–182. [PubMed] [Google Scholar]

62. Welch M.P., Odland G.F., Clark R.A. Temporal relationships of F-actin bundle germination, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction. J Prison cell Biol. 1990;110:133–145. [PMC free article] [PubMed] [Google Scholar]

63. Osborne C.South., Reid W.H., Grant M.H. Investigation into the biological stability of collagen/chondroitin-6-sulphate gels and their wrinkle past fibroblasts and keratinocytes: the effect of crosslinking agents and diamines. Biomaterials. 1999;20:283–290. [PubMed] [Google Scholar]

64. Green H., Kehinde O., Thomas J. Growth of cultured human being epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci U S A. 1979;76:5665–5668. [PMC free article] [PubMed] [Google Scholar]

65. Denefle J.P., Lechaire J.P., Zhu Q.50. Cultured epidermis influences the fibril organization of purified type I collagen gels. Tissue Prison cell. 1987;xix:469–478. [PubMed] [Google Scholar]

66. Ghosh M.One thousand., Boyce S., Layton C., Freedlander Eastward., Mac Neil South. A comparison of methodologies for the preparation of homo epidermal-dermal composites. Ann Plast Surg. 1997;39:390–404. [PubMed] [Google Scholar]

67. Harrison C.A., Gossiel F., Layton C.M., Bullock A.J., Johnson T., Blumsohn A. Utilise of an in vitro model of tissue-engineered pare to investigate the mechanism of skin graft contraction. Tissue Eng. 2006;12:3119–3133. [PubMed] [Google Scholar]

68. Harrison C.A., Heaton M.J., Layton C.Yard., Mac Neil S. Use of an in vitro model of tissue-engineered human peel to study keratinocyte attachment and migration in the process of reepithelialization. Wound Repair Regen. 2006;fourteen:203–209. [PubMed] [Google Scholar]

69. Ralston D.R., Layton C., Dalley A.J., Boyce S.G., Freedlander East., MacNeil S. Keratinocytes contract human being dermal extracellular matrix and reduce soluble fibronectin production past fibroblasts in a skin composite model. Br J Plast Surg. 1997;50:408–415. [PubMed] [Google Scholar]

70. Chakrabarty Thou.H., Heaton 1000., Dalley A.J., Dawson R.A., Freedlander E., Khaw P.T. Keratinocyte-driven wrinkle of reconstructed human peel. Wound Repair Regen. 2001;ix:95–106. [PubMed] [Google Scholar]

71. Redden R.A., Doolin E.J. Collagen crosslinking and prison cell density take distinct furnishings on fibroblast-mediated contraction of collagen gels. Skin Res Technol. 2003;nine:290–293. [PubMed] [Google Scholar]

72. Raya-Rivera A., Esquiliano D.R., Yoo J.J., Lopez-Bayghen E., Soker S., Atala A. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet. 2011;377:1175–1182. [PMC costless article] [PubMed] [Google Scholar]

73. Lee T.Y., Chin G.Due south., Kim W.J., Chau D., Gittes G.One thousand., Longaker M.T. Expression of transforming growth factor beta i, 2, and three proteins in keloids. Ann Plast Surg. 1999;43:179–184. [PubMed] [Google Scholar]

74. Steenfos H., Spencer Due east.M., Chase T. Insulin-similar growth factor I has a major role in wound healing. Surg Forum. 1989;forty:68. [Google Scholar]

75. Scharffetter K., Heckmann M., Hatamochi A., Mauch C., Stein B., Riethmuller Thousand. Synergistic effect of tumor necrosis gene-alpha and interferon-gamma on collagen synthesis of human skin fibroblasts in vitro. Exp Cell Res. 1989;181:409–419. [PubMed] [Google Scholar]

76. Ghahary A., Shen Y.J., Nedelec B., Scott P.M., Tredget E.Eastward. Enhanced expression of mRNA for insulin-similar growth factor-i in post-burn down hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem. 1995;148:25–32. [PubMed] [Google Scholar]

77. El-Kassaby A., Abou Shwareb T., Atala A. Randomized comparative report betwixt buccal mucosal and acellular bladder matrix grafts in complex anterior urethral strictures. J Urol. 2008;179:1432–1436. [PubMed] [Google Scholar]

78. Fossum M., Skikuniene J., Orrego A., Nordenskjold A. Prepubertal follow-up subsequently hypospadias repair with autologous in vitro cultured urothelial cells. Acta Paediatr. 2012;101:755–760. [PubMed] [Google Scholar]

79. Patterson J.M., Bullock A.J., MacNeil Due south., Chapple C.R. Methods to reduce the contraction of tissue-engineered buccal mucosa for utilize in exchange urethroplasty. Eur Urol. 2011;60:856–861. [PubMed] [Google Scholar]

lxxx. Breyer B.N., McAninch J.W., Whitson J.M., Eisenberg Chiliad.L., Mehdizadeh J.F., Myers J.B. Multivariate analysis of risk factors for long-term urethroplasty outcome. J Urol. 2010;183:613–617. [PubMed] [Google Scholar]

81. Kinnaird A.S., Levine M.A., Ambati D., Zorn J.D., Rourke K.F. Stricture length and etiology as preoperative independent predictors of recurrence afterward urethroplasty: a multivariate analysis of 604 urethroplasties. Tin can Urol Assoc J. 2014;8:E296–E300. [PMC gratis article] [PubMed] [Google Scholar]

82. Warner J.North., Malkawi I., Dhradkeh One thousand., Joshi P.M., Kulkarni South.B., Lazzeri Yard. A multi-institutional evaluation of the management and outcomes of long-segment urethral strictures. Urology. 2015;85:1483–1487. [PubMed] [Google Scholar]

83. Han J.S., Liu J., Hofer M.D., Fuchs A., Chi A., Stein D. Risk of urethral stricture recurrence increases over fourth dimension subsequently urethroplasty. Int J Urol. 2015;22:695–699. [PubMed] [Google Scholar]

84. Worrall S., de Jersey J., Nicholls R., Wilce P. Acetaldehyde/poly peptide interactions: are they involved in the pathogenesis of alcoholic liver disease? Dig Dis. 1993;xi:265–277. [PubMed] [Google Scholar]

85. Miller Y.I., Choi S.H., Wiesner P., Fang Fifty., Harkewicz R., Hartvigsen K. Oxidation-specific epitopes are danger-associated molecular patterns recognized past blueprint recognition receptors of innate immunity. Circ Res. 2011;108:235–248. [PMC free article] [PubMed] [Google Scholar]

86. Wick G., Brunner H., Penner Eastward., Timpl R. The diagnostic application of specific antiprocollagen sera. 2. Analysis of liver biopsies. Int Arch Allergy Appl Immunol. 1978;56:316–324. [PubMed] [Google Scholar]

87. Wick K., Grundtman C., Mayerl C., Wimpissinger T.F., Feichtinger J., Zelger B. The immunology of fibrosis. Annu Rev Immunol. 2013;31:107–135. [PubMed] [Google Scholar]

88. Grenier S., Sandig M., Mequanint K. Smooth muscle alpha-actin and calponin expression and extracellular matrix production of human coronary artery smooth muscle cells in 3D scaffolds. Tissue Eng Part A. 2009;15:3001–3011. [PubMed] [Google Scholar]

89. Shih B., Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol. 2010;half-dozen:715–726. [PubMed] [Google Scholar]

xc. Strutz F., Neilson E.G. New insights into mechanisms of fibrosis in immune renal injury. Springer Semin Immunopathol. 2003;24:459–476. [PubMed] [Google Scholar]

Articles from Asian Journal of Urology are provided here courtesy of 2nd Military Medical University